Flyers' Lindblom diagnosed with Ewing's sarcoma

Philadelphia Flyers forward Oskar Lindblom will likely miss the rest of the season after being diagnosed with Ewing's sarcoma, a rare bone cancer. The Flyers said the diagnosis was made by "leading specialists" at the University of Pennsylvania.

The 23-year-old Lindblom is scheduled to undergo further testing and evaluation next week. He is slated to begin treatments immediately after the testing and evaluations are complete. "The Flyers will do everything possible to support Oskar and assist him in securing the best care available," general manager Chuck Fletcher said in a statement. "Out of respect for Oskar and his family, the team will have no further comment at this time."

Ewing's sarcoma is cancer that occurs in bones or in the soft tissue that forms around the bones, according to the Mayo Clinic. Lindblom, who hails from Sweden, has 11 goals and seven assists (18 points) in 30 games this season. He is tied for the team lead in goals with Travis Konecny.

Lindblom missed Wednesday's game against the Colorado Avalanche with what the team said was an upper-body injury. Lindblom has 30 goals and 27 assists (57 points) in 134 NHL games over parts of the past three seasons.

 

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)